Psyence Biomedical Debt to Equity Ratio Trends

Psyence Biomedical Ltd. (PBM)

4.19 +0.04 (+0.96%) USD | NASDAQ | Jun 01, 16:00

4.20 +0.01 (+0.24%) After-Hours: 07:00

Debt to Equity Ratio Chart

View Debt to Equity Ratio for PBM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Debt to Equity Ratio Chart

Start Trial

Historical Data

View Historical Data

Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition

Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks

Start Trial

Xenon Pharmaceuticals, Inc.	0.0056
Clearmind Medicine, Inc.	0.001
Aurinia Pharmaceuticals, Inc.	0.1209
enGene Therapeutics, Inc.	0.1189
Medicus Pharma Ltd.	1.911